Search filters

List of works by Jeffrey R Currier

A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells

scientific article published on 16 September 2011

A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection

scientific article

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

scientific article published on 01 February 2002

Analysis of cell-mediated immune responses in support of dengue vaccine development efforts

scientific article published on 09 October 2015

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees

scientific article

CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients

scientific article published on 20 December 2006

CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.

scientific article

Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire

scientific article published on 24 November 2010

Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1

scientific article published on 22 January 2020

Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.

scientific article

Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles

scientific article

Defining epitope coverage requirements for T cell-based HIV vaccines: Theoretical considerations and practical applications ⬇️

scientific article published on December 8, 2011

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines

scientific article published on 03 August 2009

Designing the epitope flanking regions for optimal generation of CTL epitopes.

scientific article published on 2 May 2014

Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans

scientific article published on October 2003

Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and cellular metabolic profiling

Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions

scientific article published on 20 July 2016

Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection

scientific article published on August 2009

HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides

scientific article published in July 2005

HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses

scientific article

HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians

scientific article published in June 2004

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens

scientific article

High-throughput high-resolution class I HLA genotyping in East Africa

scientific article

Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif

scientific article

Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E.

scientific article

Immunodominance and Cross-Reactivity of B5703-Restricted CD8 T Lymphocytes from HIV Type 1 Subtype C-Infected Ethiopians

article

Immunopathogenesis Versus Protection in Dengue Virus Infections

scientific article published on March 2014

In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype

scientific article

Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans

scientific article

Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand

scientific article published in 2019

Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistance.

scientific article published on January 2004

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells

article

OMIP-007: phenotypic analysis of human natural killer cells

scientific article published on 12 March 2012

Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment

scientific article

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate

scientific article

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

scientific article

Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells

scientific article published on 7 October 2002

Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection.

scientific article published on 17 December 2018

Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial

scientific article

Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection

scientific article published in September 2012

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization ⬇️

scientific article published on April 11, 2012

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

scientific article

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope ⬇️

scientific article published on April 23, 2012

Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination.

scientific article published on 23 March 2018

Paulina is supported by:

About Paulina

Help